SPIRIT: switching to emtricitabine/rilpivirine/tenofovir DF single-tablet regimen from boosted protease inhibitor maintains HIV suppression at week 48
Fisher, M, Palella, F, Tebas, P, Gazzard, B, Ruane, P, van Lunzen, J, Shamblaw, D, Flamm, J, Ebrahimi, R, White, K, Guyer, W, Porter, D, Fralich, TVolume:
15
Language:
english
Journal:
Journal of the International AIDS Society
DOI:
10.7448/IAS.15.6.18275
Date:
November, 2012
File:
PDF, 168 KB
english, 2012